Dr Liang Qiao

Senior Research Fellow
Medicine, Westmead Clinical School

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: 9845 9131
F: 9845 9103
E:

Publications

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

2014

   
  • O'Connor, M., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Wang, Z., Qiao, L., Duan, W. (2014), Cancer stem cells: A contentious hypothesis now moving forward. Cancer Letters. 344(2), 180-187. [Abstract]
  • Qiao, L. (2014), Cancer Letters special issue inflammation andgastrointestinal and liver cancers featuring the guest editor. Cancer Letters. 345, 149. [Abstract]
  • Qiao, L., Li, X. (2014), Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now. Cancer Letters. 345(2), 150-152. [Abstract]
  • Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y., Hebbard, L., George, J., Qiao, L. (2014), Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling. Molecular Cancer Therapeutics. 13(5), 1206-1216. [Abstract]
  • Wang, F., Meng, W., Wang, B., Qiao, L. (2014), Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Letters. 345(2), 196-202. [Abstract]
  • Duan, X., Zhang, L., Fan, J., Qiao, L. (2014), NAFLD leads to liver cancer: do we have sufficient evidence?. Cancer Letters. 345(2), 230-234. [Abstract]
  • Xu, C., Zhou, W., Wang, Y., Qiao, L. (2014), Hepatitis B virus-induced hepatocellular carcinoma. Cancer Letters. 345(2), 216-222. [Abstract]
  • Peng, M., Xu, S., Zhang, Y., Zhang, L., Huang, B., Fu, S., Xue, Z., Da, Y., Dai, Y., Qiao, L., Dong, A., Zhang, R., Meng, W. (2014), Thermosensitive injectable hydrogel enhances the antitumor effect of embelin in mouse hepatocellular carcinoma. Journal of Pharmaceutical Sciences. 103(3), 965-973. [Abstract]
  • Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D., Zhang, R., Ebert, M., Chen, J., Wong, B., Chan, K., George, J., Qiao, L. (2014), Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death & Disease. 5, e1170. [Abstract]

2013

   
  • Vongsuvanh, R., George, J., Qiao, L., Poorten, D. (2013), Visceral Adiposity In Gastrointestinal And Hepatic Carcinogenesis. Cancer Letters. 330(1), 1-10. [Abstract]
  • Liu, X., Chen, Z., Li, H., Hu, Z., Liu, M., Tian, A., Zhao, D., Wu, J., Zhou, Y., Qiao, L. (2013), Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells. World Journal of Gastroenterology. 19(37), 6265-62771. [Abstract]
  • Wang, Y., Li, Y., Li, X., Liu, T., Liu, X., Zhang, J., Guo, J., Guo, L., Qiao, L. (2013), Hypermethylation of TGF-β1 gene promoter in gastric cancer. World Journal of Gastroenterology. 19(33), 5557-5564. [Abstract]
  • Wilson, G., Tian, A., Hebbard, L., Duan, W., George, J., Li, X., Qiao, L. (2013), Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro. Cancer Letters. 341(2), 224-230. [Abstract]
  • Chen, Z., Liu, M., Liu, X., Huang, S., Li, L., Song, B., Li, H., Ren, Q., Hu, Z., Zhou, Y., Qiao, L. (2013), COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. International Journal of Molecular Medicine. 32(1), 93-100. [Abstract]
  • Wilson, G., Hu, Z., Duan, W., Tian, A., Wang, X., McCleod, D., Lam, V., George, J., Qiao, L. (2013), Efficacy of using cancer stem cell markers in isolating and characterising liver cancer stem cells. Stem Cells and Development. 22(19), 2655-2664. [Abstract]
  • Hu, Z., Liu, X., Tang, Z., Zhou, Y., Qiao, L. (2013), Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer. Oncology Reports. 29(3), 993-1000. [Abstract]
  • Shigdar, S., Qiao, L., Zhou, S., Xiang, D., Wang, T., Li, Y., Lim, L., Kong, L., Li, L., Duan, W. (2013), RNA aptamers targeting cancer stem cell marker CD133. Cancer Letters. 330(1), 84-95. [Abstract]
  • Shigdar, S., Macdonald, J., O'Connor, M., Wang, T., Xiang, D., Al Shamaileh, H., Qiao, L., Wei, M., Zhou, S., Zhu, Y., Kong, L., Bhattacharya, S., Li, C., Duan, W. (2013), Aptamers as theranostic agents: modifications, serum stability and functionalisation. Sensors. 13(10), 13624-13637. [Abstract]

2012

   
  • Jiang, X., Huang, K., Yang, M., Qiao, L., Wang, Q., Ye, J., Zhou, H., Yi, Z., Wu, F., Wang, Z., Zhao, Q., Meng, F. (2012), Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways. Cancer Letters. 326(2), 135-142. [Abstract]
  • Guo, L., Li, Y., Qiao, L., Liu, T., Du, Y., Zhang, J., He, W., Zhao, Y., He, D. (2012), Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. World Journal of Gastroenterology. 18(48), 7262-7270. [Abstract]
  • Qiao, L., George, J., Li, Y., Yan, X. (2012), Molecular Aspects of Hepatocellular Carcinoma. United States: Bentham Science Publishers Ltd..
  • Li, Z., Chim, J., Yang, M., Ye, J., Wong, B., Qiao, L. (2012), Role of PCDH10 and its hypermethylation in human gastric cancer. Biochimica et Biophysica Acta. 1823(2), 298-305. [Abstract]
  • Duan, X., Qiao, L., Fan, J. (2012), Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International. 11(1), 18-27. [Abstract]
  • Liu, Q., Zhou, Y., Qiao, L. (2012), An Overview on Molecular Therapy for Hepatocellular Carcinoma. In: Molecular Aspects of Hepatocellular Carcinoma. (pp.138-148).United States: Bentham Science Publishers Ltd..
  • Wang, F., Wang, B., Qiao, L. (2012), Association between obesity and gallbladder cancer. Frontiers in Bioscience. 17, 2550-2558. [Abstract]
  • Li, Q., Zhang, J., Zhou, Y., Qiao, L. (2012), Obesity and gastric cancer. Frontiers in Bioscience. 17, 2383-2390. [Abstract]
  • Shen, C., Zhao, C., Zhang, R., Qiao, L. (2012), Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Frontiers in Bioscience. 17, 2356-2370. [Abstract]
  • Tian, A., Qiao, L., Yan, X. (2012), Aging and Hepatocellular Carcinoma: Possible Molecular Mechanisms. In: Molecular Aspects of Hepatocellular Carcinoma. (pp.80-85).United States: Bentham Science Publishers Ltd..
  • Zhao, C., Liu, X., Shen, C., Wang, Y., Qiao, L. (2012), Treatment of Hepatocellular Carcinoma with Traditional Chinese Medicine: Possible Molecular Mechanisms. In: Molecular Aspects of Hepatocellular Carcinoma. (pp.167-173).United States: Bentham Science Publishers Ltd..

2011

   
  • Li, Z., Chen, J., Chan, K., Qiao, L., Wong, B. (2011), A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Letters. 313(2), 192-200. [Abstract]
  • Wu, J., Lu, H., Ling, X., Wang, C., Rui, J., Wang, A., Qiao, L. (2011), {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D: -Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line. Medical oncology (Northwood, London, England). 28(4), 986-90. [Abstract]
  • Liu, S., Chan, K., Tong, J., Wang, Y., Wang, B., Qiao, L. (2011), PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature. QJM : monthly journal of the Association of Physicians. 104(6), 477-83. [Abstract]

2010

   
  • Zhou, Y., Li, G., Wu, J., Zhang, Z., Wu, Z., Fan, P., Hao, T., Zhang, X., Li, M., Zhang, F., Li, Q., Lu, B., Qiao, L. (2010), Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumour Biology. 31(6), 549-558. [Abstract]
  • Ye, J., Chan, G., Qiao, L., Lian, Q., Meng, F., Luo, X., Khachigian, L., Ma, M., Deng, R., Chen, J., Chong, B., Yang, M. (2010), Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica. 95(10), 1745-1753. [Abstract]

2009

   
  • Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan, S., Qiao, L., Jiang, B., Tu, S., Ma, J., Hung, I., Lan, H., Wong, B. (2009), Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer. Carcinogenesis. 30(9), 1507-1516. [Abstract]
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Ma, J., Zou, B., Gu, Q., Wang, J., Pang, R., Lan, H., Wong, B. (2009), Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Research. 69(11), 4776-4783. [Abstract]
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Zhang, R., Ma, J., Zou, B., Lam, C., Wang, J., Pang, R., Tan, V., Lan, H., Wong, B. (2009), Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer. Molecular Cancer Therapeutics. 8(9), 2762-2770. [Abstract]
  • Liu, S., Chan, K., Wang, B., Qiao, L. (2009), Fibrolamellar Hepatocellular Carcinoma. American Journal of Gastroenterology. 104(10), 2617-2624. [Abstract]
  • Qiao, L., Wong, B. (2009), Role of Notch signaling in colorectal cancer. Carcinogenesis. 30(12), 1979-1986. [Abstract]

2008

   
  • Zhou, Y., Zhang, Z., Zhang, Z., Wu, J., Ren, D., Yan, X., Wang, Q., Wang, Y., Wang, H., Zhang, J., Zhu, X., Yang, Y., Luo, C., Guo, X., Tang, C., Qiao, L. (2008), A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Letters. 269(1), 18-25. [Abstract]
  • Ma, J., Yang, X., Qiao, L., Liang, L., Chen, M. (2008), CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy. Journal of Digestive Diseases. 9(2), 79-83. [Abstract]